AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Date of Call: November 11, 2025
backlog of approximately $90 million, more than four times the levels of just a few short quarters ago. - The growth was fueled by a strategic shift up the value chain, integrating proprietary materials and design expertise into complete imaging systems, particularly those using Black Diamond Chalcogenide glass as a domestic alternative to germanium.$8 million equity investment from Ondas Holdings and Unusual Machines.These investments are intended to accelerate the commercialization roadmap, focusing on uncooled infrared solutions for drone applications, while also supporting the reshoring of advanced optical and imaging technologies to the U.S. and Europe.
Gross Profit and Margin Expansion:

58% to $4.5 million, or 30% of total revenues in the first quarter of 2026, compared to 2.8 million, or 34% of total revenues in the same year ago quarter.This trend was driven by the growth in higher-margin systems and subsystems, which now make up more than two-thirds of the company's backlog, despite certain non-recurring orders impacting the gross margin as a percentage of revenue.
Diversified Product and Market Expansion:
39% of consolidated revenue, with significant growth in the defense, public safety, and industrial markets.
Overall Tone: Positive
Contradiction Point 1
Gross Margin Expectations
It involves changes in financial forecasts, specifically regarding gross margin expectations, which are critical indicators for investors.
Can you discuss gross margin trends and expectations? - Glenn Matson(Ladenburg Thalmann)
2026Q1: Gross margin was impacted by sales mix, particularly high IR component sales. Target is to increase margins to 35% by year-end, reflecting expected higher contributions from systems and modules. - Al Miranda(CFO)
What is the pipeline size after converting to backlog? - Richard Shannon(Craig-Hallum)
2025Q4: We aim to increase gross margins to 35% in the short term and potentially 40% in the midterm through product mix changes. - Albert Miranda(CFO)
Contradiction Point 2
Backlog Attribution to G5
It involves clarification on the attribution of the backlog to G5, which impacts revenue and growth expectations.
How is G5 backlog affecting overall backlog? - Jason Schmidt(Lake Street Capital Markets)
2026Q1: G5 backlog still contributes about two-thirds to the overall backlog. - Sam Rubin(CEO)
What was G5's revenue contribution in the last quarter, and what portion of the $90 million backlog is attributed to G5? - Jaeson Schmidt(Lake Street Capital Markets)
2025Q4: The $90 million backlog has about 2/3 attributed to systems and subsystems that G5 is part of. - Albert Miranda(CFO)
Contradiction Point 3
Impact of Converting Germanium to Black Diamond Glass
It affects the company's ability to meet customer demands and maintain the existing order pipeline.
Can you discuss the germanium market and your transition of camera and sub-assemblies to Black Diamond glass? - Richard Shannon(Craig-Hallum)
2026Q1: We are in the middle of those conversions. Priorities are on short-term revenue. We are in the middle of those conversions. - Sam Rubin(CEO)
What does expanding Visimid capacity signal? - Glenn Mattson(Ladenburg Thalmann & Co.)
2025Q4: We have lots of manufacturing capacity. We've got more than 3-quarters of the production capacity that's needed to support the G5 scalable growth. - Sam Rubin(President, CEO)
Contradiction Point 4
Supply Chain Resiliency and Capacity Improvements
It directly impacts the company's ability to meet production demands and deliver products on time, which is crucial for customer satisfaction and revenue.
Can you discuss supply chain resiliency and capacity improvements? - Richard Shannon(Craig Hallam)
2026Q1: Capacity is being added across all areas except molded optics. Key investments are in glass production and camera assembly. Some constraints from supplier focal plane arrays are being addressed through alternative materials or replacement. Vertically integrated supply chain is being expanded. - Sam Rubin(CEO)
Are there capacity constraints on the G5 side, and can production be relocated to Orlando? - Scott Buck(H. C. Wainwright)
2025Q3: Capacity is not an issue, but there are complexities in sourcing components. The single vendor for detectors and obtaining optics could be supported by LightPath's operations. - Sam Rubin(CEO)
Contradiction Point 5
Sales Progression and EBITDA Trends
It involves the company's guidance on sales progression and EBITDA expectations, which are crucial for investor confidence and financial planning.
Can you provide guidance on sales progression and EBITDA trends? - Richard Shannon(Craig Hallam)
2026Q1: We're not offering specific guidance, but we're satisfied with Q1 sales. For EBITDA, we aims to maintain positive EBITDA, supported by margin improvements as higher-margin systems contribute more to revenue. - Al Miranda(CFO)
Will the combined company be profitable in the next few quarters, given G5's seasonality? - Brian Kinstlinger(Alliance Global Partners)
2025Q2: We're doing well on sales. We're not offering specific guidance. But we're on track to meet our annual sales plan. From an EBITDA perspective, the first half of the year was encouraging, and we should see a slight margin expansion sequentially. - Al Miranda(CFO)
Discover what executives don't want to reveal in conference calls

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet